Sec. 2. Opioid advertising and consumer safety
213 words·~1 min read·
/bill/115/s/2440/is/section-2A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 503C of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 353c ) is amended— in subsection (a), by striking The Secretary and inserting Subject to subsection (f), the Secretary ; in subsection (c), by inserting or
(f)after subsection
(e); by redesignating subsection
(f)as subsection (g); and by inserting after subsection
(e)the following: In the case of a television advertisement for a controlled substance (as defined in section 102 of the Controlled Substances Act)— the Secretary shall require the submission of such advertisement under subsection (a); and the sponsor of such advertisement may not disseminate the advertisement until the Secretary has conducted the review under this section. There is authorized to be appropriated $5,000,000 for the period of fiscal years 2019 through 2023 to increase the proficiency and speed of the Secretary in conducting and reviewing television advertisements for controlled substances (as so defined) under this section. . Section 301 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 331 ) is amended by adding at the end the following: The failure to comply with the requirements under section 503C(f). . No amendment made by this section shall preclude the enforcement, under any relevant civil or other enforcement authority, of a State consumer protection statute.
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources